Shrestha et al. (2023); remember, this study showed us that among 51,017 working-aged Cleveland Clinic employees, the bivalent COVID-19 mRNA technology vaccine was 29% effective in preventing

by Paul Alexander

infection while the BA.4/5 lineages were dominant, and 20% effective while the BQ lineages were; a clear dose-response was seen & I had to re-post the graph;


“Risk of COVID-19 increased with time since the most recent prior COVID-19 episode and with the number of vaccine doses previously received.”